Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial

Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial

(2012) Chuan-Jie Wu et al.   CEPHALALGIA

Reference programme: Diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012

(2012) Lars Bendtsen et al.   JOURNAL OF HEADACHE AND PAIN

Botulinum toxin type-A effect as a preemptive treatment in a model of acute trigeminal pain: a pre-clinical double-blind and placebo-controlled study

(2011) Elcio Juliato Piovesan et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

A prospective study of 39 patients with trigeminal neuralgia treated with percutaneous balloon compression

(2011) Wuilker Knoner Campos et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Trigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial pain

(2011) J. M. Zakrzewska et al.   POSTGRADUATE MEDICAL JOURNAL

Botulinum toxin in headache treatment: Finally a promising path?

(2010) Jean Schoenen   CEPHALALGIA

OnabotulinumtoxinA for the treatment of chronic migraine not quite there. . .

(2010) Josh Torgovnick   CEPHALALGIA

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

(2010) SK Aurora et al.   CEPHALALGIA

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

(2010) HC Diener et al.   CEPHALALGIA

Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain

(2010) Wei Cheong Ngeow et al.   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS

Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report

(2010) Behnam Bohluli et al.   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS

Activation of TRPV1 Mediates Calcitonin Gene-Related Peptide Release, Which Excites Trigeminal Sensory Neurons and Is Attenuated by a Retargeted Botulinum Toxin with Anti-Nociceptive Potential

(2009) J. Meng et al.   JOURNAL OF NEUROSCIENCE

Beneficial effects of botulinum toxin type A in trigeminal neuralgia

(2008) Carlos Zúñiga et al.   ARQUIVOS DE NEURO-PSIQUIATRIA